1. Home
  2. RLMD vs CHMG Comparison

RLMD vs CHMG Comparison

Compare RLMD & CHMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

SELL

Current Price

$3.06

Market Cap

348.8M

Sector

Health Care

ML Signal

SELL

Logo Chemung Financial Corp

CHMG

Chemung Financial Corp

N/A

Current Price

$83.56

Market Cap

415.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
RLMD
CHMG
Founded
2004
1833
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
348.8M
415.9M
IPO Year
2012
1995

Fundamental Metrics

Financial Performance
Metric
RLMD
CHMG
Price
$3.06
$83.56
Analyst Decision
Strong Buy
Buy
Analyst Count
4
5
Target Price
$10.75
★ $92.35
AVG Volume (30 Days)
★ 1.7M
48.9K
Earning Date
11-12-2026
10-22-2026
Dividend Yield
N/A
★ 1.69%
EPS Growth
★ 45.28
N/A
EPS
N/A
★ 6.36
Revenue
★ $13,070.00
N/A
Revenue This Year
N/A
$31.95
Revenue Next Year
N/A
$7.35
P/E Ratio
★ N/A
$13.37
Revenue Growth
★ 154.83
N/A
52 Week Low
$3.07
$50.31
52 Week High
$8.00
$89.34

Technical Indicators

Market Signals
Indicator
RLMD
CHMG
Relative Strength Index (RSI) 37.32 47.90
Support Level N/A $83.83
Resistance Level $3.55 $84.69
Average True Range (ATR) 0.43 2.01
MACD -0.04 -0.27
Stochastic Oscillator 4.05 13.43

Price Performance

Historical Comparison
RLMD
CHMG

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

About CHMG Chemung Financial Corp

Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.

Share on Social Networks: